• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cell Mol Med . Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 an

tetano

Editor, Senior Moderator
J Cell Mol Med


. 2022 Sep 8.
doi: 10.1111/jcmm.17492. Online ahead of print.
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors


Andrea Latini[SUP] 1 [/SUP], Chiara Vancheri[SUP] 1 [/SUP], Francesca Amati[SUP] 1 [/SUP], Elena Morini[SUP] 1 [/SUP], Sandro Grelli[SUP] 2 [/SUP], Matteucci Claudia[SUP] 2 [/SUP], Petrone Vita[SUP] 2 [/SUP], Vito Luigi Colona[SUP] 3 [/SUP], Michela Murdocca[SUP] 1 [/SUP], Massimo Andreoni[SUP] 4 [/SUP], Vincenzo Malagnino[SUP] 4 [/SUP], Massimiliano Raponi[SUP] 5 [/SUP], Dario Cocciadiferro[SUP] 5 [/SUP], Antonio Novelli[SUP] 5 [/SUP], Paola Borgiani[SUP] 1 [/SUP], Giuseppe Novelli[SUP] 1 5 6 7 [/SUP]



Affiliations

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the novel coronavirus responsible for worldwide coronavirus disease (COVID-19). We previously observed that Angiotensin-converting enzyme 2 (ACE2) and Dipeptidyl peptidase-4 (DPP4) are significantly overexpressed in naso-oropharyngeal swabs (NPS) of COVID-19 patients, suggesting their putative functional role in the disease progression. ACE2 and DPP4 overexpression in COVID-19 patients may be associated to epigenetic mechanism, such as miRNA differential expression. We investigated if hsa-let7b-5p, reported to target both ACE2 and DPP4 transcripts, could be involved in the regulation of these genes. We verified that the inhibition and overexpression of hsa-let7b-5p matched to a modulation of both ACE2 and DPP4 levels. Then, we observed a statistically significant downregulation (FC = -1.5; p < 0.05) of hsa-let7b-5p in the same COVID-19 and control samples of our previous study. This is the first study that shows hsa-let7b-5p low expression in naso-oropharyngeal swabs of COVID-19 patients and demonstrates a functional role of this miR in regulating ACE2 and DPP4 levels. These data suggest the involvement of hsa-let7b-5p in the regulation of genes necessary for SARS-CoV-2 infections and its putative role as a therapeutic target for COVID-19.

Keywords: ACE2; COVID-19; DPP4; SARS-CoV-2; hsa-let7b-5p; miRNAs.
 
Back
Top Bottom